Alkis Papachristos, PharmD, PhD (@alkis_p) profile picture

Postdoctoral Fellow in Clinical Pharmacology and Pharmacogenomics at University of Chicago • Tweets are my own

Chicago, IL
Joined July 2011
Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)Photo by Alkis Papachristos, PharmD, PhD (@alkis_p)
📢 @ACSCAN #Pharmacogenomics summit is happening tomorrow! Join Peter O’Donnell, MD from @UChicagoMed, to learn about University of Chicago’s experiences with prospective PGx testing in it's cancer patient populations. @UCCancerCenter @UChicagoHemOnc ow.ly/87mA50OZIMP
1
2
5
1,345
#ASCO23 day 2 kicks off! Looking forward to the Developmental Therapeutics poster session - Immunotherapy & Molecularly Targeted agents #Immunotherapy #Immunooncoloy #TargetedTreatments🧬@ASCO #CancerResearch
2
135
Alkis Papachristos, PharmD, PhD retweeted
A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens. ms.spr.ly/6010bZRxk
2
3
Last day of #ASCO2022 @ASCO it was great to be back in #Chicago, learn the latest advances in #oncology #immunoOncology and meeting many friends and colleagues. See you next year!
3
Excited to attend Pharmacogenetic testing to personalize cancer therapy: ready or not? @ASCO #ASCO2022 moderated by Dr. O’Donnell – at Chicago, IL
1
Starting at 3 PM: Dr. Peter O'Donnell will moderate a panel discussion on the state of pharmacogenetic testing to personalize cancer therapy. meetings.asco.org/2022-asco-… #ASCO22
2
6
Day 3 @ASCO #ASCO2022 starts 🔜 Looking forward to the Developmental Therapeutics-Immunotherapy poster session #Immunotherapy #immunoOncology #biomarker – at Chicago, IL
1
#ASCO22 is loading @ASCO. Excited to learn the latest science and see many friends and colleagues in Chicago
1
4
Alkis Papachristos, PharmD, PhD retweeted
Today's the day - a superb lineup of speakers and panelists on #Gettingthedoseright. Along with Dr. Mirat Shah @FDAOncology, we'll be kicking off Day 1 in 2 short hours with @realrickpazdur and @lillian_siu. Ready to talk #oncopharm #clinicaltrials and all things dose-related
1
3
20
Alkis Papachristos, PharmD, PhD retweeted
New article: Lurbinectedin-induced thrombocytopenia: the role of body surface area link.paperbirds.me/SMnv67 #lungcancer #oncology
1
1
Alkis Papachristos, PharmD, PhD retweeted
Our lab at @NIAIDNews @NIH is hiring a Staff Scientist to work in bench-to-bedside research projects in the areas of fungal immunology, inflammation and autoimmunity. Reach out if you are interested and please retweet! niaid.nih.gov/about/staff-sc…
1
66
3
87
Alkis Papachristos, PharmD, PhD retweeted
Nice review on the influence of inflammation on CYP450 activity. TAKE HOME: Inflammation down-regulates CYP3A, CYP1A2, & CYP2C19 activity but has no/minimal impact on CYP2D6 activity. Important to consider when interpreting & implementing PGx testing. frontiersin.org/article/10.3…
1
19
1
29